Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 43, Issue 10 (Oct 2005)

Issues

Homocysteine and B vitamins in mild cognitive impairment and dementia

Pierluigi Quadri
  • Geriatric Division and Department of Metabolic Diseases, Ospedale Regionale della Beata Vergine, Mendrisio, Switzerland
/ Claudia Fragiacomo
  • Geriatric Division and Department of Metabolic Diseases, Ospedale Regionale della Beata Vergine, Mendrisio, Switzerland
/ Rita Pezzati
  • Geriatric Division and Department of Metabolic Diseases, Ospedale Regionale della Beata Vergine, Mendrisio, Switzerland
/ Enrica Zanda
  • Geriatric Division and Department of Metabolic Diseases, Ospedale Regionale della Beata Vergine, Mendrisio, Switzerland
/ Mauro Tettamanti
  • Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
/ Ugo Lucca
  • Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
Published Online: 2011-09-21 | DOI: https://doi.org/10.1515/CCLM.2005.191

Abstract

Elderly subjects with mild cognitive impairment have a high risk for conversion to Alzheimer's disease or are already in a preclinical dementia stage. By cross-sectionally comparing subjects in prodromal and early phases of dementia with non-demented controls, we tested the hypothesis whether low serum vitamin B12 and folate and high plasma total homocysteine concentrations precede or are a consequence of dementia onset. From a large population of 623 consecutive subjects seen at the Memory Clinic (Ospedale Beata Vergine, Mendrisio, Switzerland), 433 subjects could be included in the analyses: 79 elderly controls, 218 Clinical Dementia Rating 0.5 subjects, and 136 demented patients (111 with Alzheimer's disease and 25 with vascular dementia). As in an earlier report on a smaller sample of the same population (n=228), the lowest folate tertile was strongly associated with mild cognitive impairment (adjusted OR=3.1) and Alzheimer's disease (adjusted OR=4.0). Hyperhomocysteinemia showed a significant association not only with Alzheimer's disease (adjusted OR=3.1) but, at variance with the previous report, also with mild cognitive impairment (adjusted OR=2.6). Present reanalysis results suggest that subclinical folate deficiency and hyperhomocysteinemia might predate dementia onset, findings to be confirmed by longitudinal studies.

Keywords: Alzheimer's disease; dementia; folate; homocysteine; mild cognitive impairment; vitamin B12

References

  • 1.

    Weir DG, Scott JM. Brain function in the elderly: role of vitamin B12 and folate. Br Med Bull 1999; 55:669–82.

  • 2.

    Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000; 71(Suppl):614S–20S.

  • 3.

    D'Anci KE, Rosenberg IH. Folate and brain function in the elderly. Curr Opin Clin Nutr Metab Care 2004; 7:659–64. [Crossref]

  • 4.

    Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 2002; 325:1202–6.

  • 5.

    The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis. J Am Med Assoc 2002;288:2015–22.

  • 6.

    Joosten E. Homocysteine, vascular dementia and Alzheimer's disease. Clin Chem Lab Med 2001; 39:717–20.

  • 7.

    Morris MS. Folate, homocysteine, and neurological function. Nutr Clin Care 2002; 5:124–32. [Crossref]

  • 8.

    Garcia A, Zanibbi K. Homocysteine and cognitive function in the elderly. CMAJ 2004; 171:897–904.

  • 9.

    Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003; 26:137–46. [Crossref]

  • 10.

    Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimerdisease, and vascular dementia. Am J Clin Nutr 2004; 80:114–22.

  • 11.

    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939–44. [Crossref]

  • 12.

    Morris JC. Clinical assessment of Alzheimer's disease. Neurology 1997; 49(Suppl 3):S7–10.

  • 13.

    Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke 1983; 14:399–401. [Crossref]

  • 14.

    Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43:2412–4. [Crossref]

  • 15.

    Nilsson K, Gustafson L, Fäldt R, Andersson A, Brattstrom L, Lindgren A, et al. Hyperhomocysteinaemia – a common finding in a psychogeriatric population. Eur J Clin Invest 1996; 26:853–9. [Crossref]

  • 16.

    Joosten E, Lesaffre E, Riezler R, Ghekiere V, Dereymaeker L, Pelemans W, et al. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol 1997; 52A:M76–9. [Crossref]

  • 17.

    Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B-12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449–55.

  • 18.

    McCaddon A, Davies G, Hudson PO, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13:235–9. [Crossref]

  • 19.

    Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dement Geriatr Cogn Disord 1999; 10:12–20. [Crossref]

  • 20.

    McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002; 33:2351–6. [Crossref]

  • 21.

    Snowdon DA, Tully CL, Smith CD, Perez Riley K, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study. Am J Clin Nutr 2000; 71:993–8.

  • 22.

    Serot JM, Christmann D, Dubost T, Bene MC, Faure GC. CSF-folate concentrations are decreased in late-onset Alzheimer's patients. J Neural Transm 2001; 108:93–9. [Crossref]

  • 23.

    Basun H, Fratiglioni L, Winbland B. Cobalamin levels are not reduced in Alzheimer's disease: results from a population-based study. J Am Geriatr Soc 1994; 42:132–6.

  • 24.

    Crystal HA, Ortof E, Frishman WH, Gruber A, Hershman D, Aronson M. Serum vitamin B-12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1994; 42:933–6.

  • 25.

    Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM. Total homocysteine and cognitive decline in a community-based sample of elderly subjects. The Rotterdam Study. Am J Epidemiol 1999; 150:283–9.

  • 26.

    Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476–83.

  • 27.

    Luchsinger JA, Tang M-X, Shea S, Miller J, Green R, Mayeaux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004; 62:1972–6. [Crossref]

  • 28.

    Carmel R, Green R, Jacobsen DW, Rasmussen K, Florea M, Azen C. Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnicpopulation: ethnic and sex differences in cobalamin and metabolite abnormalities. Am J Clin Nutr 1999; 70:904–10.

About the article

Corresponding author: Ugo Lucca, Laboratory of Geriatric Neuropsychiatry, Istituto di Ricerche Farmacologiche “Mario Negri”, Via Eritrea 62, 20157 Milan, Italy Phone: +39-02-3901-4427, Fax: +39-02-3900-1916,


Published Online: 2011-09-21

Published in Print: 2005-10-01



Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2005.191. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Cynthia K. Colapinto, Deborah L. O'Connor, Margaret Sampson, Brock Williams, and Mark S. Tremblay
Journal of Public Health, 2015, Page fdv087
[2]
Niloofar Khodabandehloo, Masoud Vakili, Zahra Hashemian, and Hadi Zare Zardini
Iranian Red Crescent Medical Journal, 2015, Volume 17, Number 6
[3]
Bhaswati Roy, Richa Trivedi, Ravindra K. Garg, Pradeep K. Gupta, Ritu Tyagi, and Rakesh K. Gupta
Magnetic Resonance Imaging, 2015, Volume 33, Number 5, Page 537
[4]
Y. Yin, Y. Fan, F. Lin, Y. Xu, and Junjian Zhang
The journal of nutrition, health & aging, 2015, Volume 19, Number 1, Page 39
[5]
M. Hasan Mohajeri, Barbara Troesch, and Peter Weber
Nutrition, 2015, Volume 31, Number 2, Page 261
[6]
Sofia Lopes da Silva, Bruno Vellas, Saskia Elemans, José Luchsinger, Patrick Kamphuis, Kristine Yaffe, John Sijben, Martine Groenendijk, and Theo Stijnen
Alzheimer's & Dementia, 2014, Volume 10, Number 4, Page 485
[7]
Evangelia Kararizou, George Paraskevas, Nikolaos Triantafyllou, George Koutsis, Maria E. Evangelopoulos, Dimitrios Mandellos, Constantinos Sfagos, and Elisabeth Kapaki
Journal of the Chinese Medical Association, 2013, Volume 76, Number 11, Page 611
[8]
Roger C.M. Ho, Mike W.L. Cheung, Erin Fu, Hlaing H. Win, Min Htet Zaw, Amanda Ng, and Anselm Mak
The American Journal of Geriatric Psychiatry, 2011, Volume 19, Number 7, Page 607
[9]
Frances Rachel Frankenburg
Harvard Review of Psychiatry, 2007, Volume 15, Number 4, Page 146
[10]
Hashem Haghdoost-Yazdi, Negin Fraidouni, Ayda Faraji, Hassan Jahanihashemi, and Mohammad Sarookhani
Behavioural Brain Research, 2012, Volume 233, Number 2, Page 375
[11]
Ali Sazci, Mavi Deniz Ozel, Ergul Emel, and Halil Atilla Idrisoglu
Genetic Testing and Molecular Biomarkers, 2012, Volume 16, Number 7, Page 716
[12]
Claudine Berr, Tasnime Nassime Akbaraly, Fati Nourashemi, and Sandrine Andrieu
La Presse Médicale, 2007, Volume 36, Number 10, Page 1431
[13]
Helen Macpherson, Kathryn A. Ellis, Avni Sali, and Andrew Pipingas
Psychopharmacology, 2012, Volume 220, Number 2, Page 351
[14]
Andrea Fuso, Vincenzina Nicolia, Laura Ricceri, Rosaria A. Cavallaro, Elisa Isopi, Franco Mangia, Maria Teresa Fiorenza, and Sigfrido Scarpa
Neurobiology of Aging, 2012, Volume 33, Number 7, Page 1482.e1
[15]
J. W. Elias and M. V. Wagster
The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 2007, Volume 62, Number Special Issue 1, Page 5
[16]
Thorleif Etgen, Horst Bickel, and Hans Förstl
Ageing Research Reviews, 2010, Volume 9, Number 3, Page 280
[17]
Nishant Tageja
European Journal of Internal Medicine, 2010, Volume 21, Number 4, Page e26
[18]
Inara J. Chacón, Aldrín E. Molero, Gloria Pino-Ramírez, José A. Luchsinger, Joseph H. Lee, and Gladys E. Maestre
International Journal of Alzheimer's Disease, 2009, Volume 2009, Page 1
[19]
C. Babiloni, P. Bosco, R. Ghidoni, C. Del Percio, R. Squitti, G. Binetti, L. Benussi, R. Ferri, G. Frisoni, B. Lanuzza, E. Cassetta, G. Anello, M. Gurzì, S. Bartesaghi, R. Lizio, M. Tombini, and P.M. Rossini
Neuroscience, 2007, Volume 145, Number 3, Page 942
[20]
Cornelius G. Bachmann, Nicolas Guth, Kathrin Helmschmied, Victor W. Armstrong, Walter Paulus, and Svenja Happe
Sleep Medicine, 2008, Volume 9, Number 4, Page 388
[21]
Ugo Lucca, Mauro Tettamanti, and Pierluigi Quadri
Alzheimer's & Dementia, 2008, Volume 4, Number 4, Page 310
[22]
Edward Reynolds
The Lancet Neurology, 2006, Volume 5, Number 11, Page 949
[23]
Stefano Zoccolella, Caterina Bendotti, Ettore Beghi, and Giancarlo Logroscino
Amyotrophic Lateral Sclerosis, 2010, Volume 11, Number 1-2, Page 140
[24]
Mohamed N Farres, Rasha Y Shahin, Nermine A Melek, Rania H El-Kabarity, and Naglaa A Arafa
Internal Medicine, 2011, Volume 50, Number 3, Page 205
[25]
Maria C. Rodriguez-Oroz, Pablo Martínez Lage, Jose Sanchez-Mut, Isabel Lamet, Javier Pagonabarraga, Jon B. Toledo, David García-Garcia, Pedro Clavero, Lluis Samaranch, Cecilia Irurzun, Juan M. Matsubara, Jaione Irigoien, Emilia Bescos, Jaime Kulisevsky, Jordi Pérez-Tur, and Jose A. Obeso
Movement Disorders, 2009, Volume 24, Number 10, Page 1437
[26]
Ralf-Joachim Schulz
Current Opinion in Clinical Nutrition and Metabolic Care, 2007, Volume 10, Number 6, Page 718
[27]
Julie A Schneider, Christy C Tangney, and Martha Clare Morris
Expert Opinion on Drug Safety, 2006, Volume 5, Number 4, Page 511
[28]
Paolo Barone, David J. Burn, Teus van Laar, Chuanchieh Hsu, Werner Poewe, and Roger M. Lane
Movement Disorders, 2008, Volume 23, Number 11, Page 1532
[29]
Jean-Sébastien Vidal, Carole Dufouil, Véronique Ducros, and Christophe Tzourio
Neuroepidemiology, 2008, Volume 30, Number 4, Page 207
[30]
Kathleen Van Dyk and Mary Sano
Neurochemical Research, 2007, Volume 32, Number 4-5, Page 893
[31]
Karin Nilsson, Lars Gustafson, and Björn Hultberg
Dementia and Geriatric Cognitive Disorders, 2007, Volume 23, Number 5, Page 321
[32]
International Journal of Geriatric Psychiatry, 2006, Volume 21, Number 5, Page 500

Comments (0)

Please log in or register to comment.
Log in